SAN DIEGO, CA -- (Marketwired) -- 05/01/14 -- Ivera Medical Corporation, headquartered in San Diego, CA, announced that the United States District Court for the Southern District of California has rendered summary judgment against some Ivera patents, in motions filed by Excelsior Medical, Hospira, and Catheter Connections. The case involves U.S. Patent Nos. 7,780,794 ("the '794 patent"), 7,985,302 ("the '302 patent"), and 8,206,514 ("the '514 patent").
"We are disappointed in the Court's decision and are evaluating our options, including an appeal of this decision, and note that these patents continue through an inter partes review process within the US Patent and Trademark office," said Bob Rogers, CEO of Ivera Medical. "Our strategy regarding intellectual property has always been to build a robust portfolio, so that an adverse ruling in one case does not impact the broader strategy. Indeed, Ivera continues to be very pleased with our progress in a Florida court patent infringement case, and the impending issuance of what will be the seminal patent in this space, for which we have an exclusive license. Further it is important to note that Ivera has freedom to operate with our Curos® Port Protectors."
Curos products employ passive disinfection to disinfect intravenous devices eliminating the technique variation found in manual procedures. With two disinfecting port protector options -- Curos Strips and individual Curos -- nurses can conveniently comply with valve disinfection protocols by simply peeling the foil seal from the distinctive green cap and twisting Curos onto the top of any luer-activated IV access port or needleless valve. Inside Curos, a 70% isopropyl alcohol (IPA) saturated sponge-like foam bathes the surface of the venous access device to provide consistent and reliable disinfection of the port surface in three minutes. Once in place, Curos maintains a clean port for up to seven days, if not removed. Extending passive disinfection and protection to male-luer connectors, Curos Tips improve disinfection compliance with IV tubing connectors and needleless syringes by immersing the exterior of the male luer in alcohol. Curos Tips come in a convenient strip dispenser that places five disinfecting Tips in easy reach of clinicians at the point of care. The cap's highly visible bright green color allows auditors to monitor caregiver disinfection practice compliance at a glance.
About Ivera Medical
Ivera Medical Corporation, a certified Minority Business Enterprise (MBE), is focused on the design, development, manufacture, marketing and sale of products that help healthcare providers reduce facility-acquired patient infections. Curos, manufactured in Carlsbad, CA, is the first disinfecting cap to be marketed in the U.S. and has received FDA's 510(k) market clearance. For more information about Curos and Ivera Medical, visit the website at www.curos.com